Evidence map›Paper›PMID 30577883›Full record

Trial reportIsrael journal of health policy research2018

Is the patient activation measure associated with adherence to colonoscopy after a positive fecal occult blood test result?

Revital Azulay, Liora Valinsky, Fabienne Hershkowitz, Racheli Magnezi

Registry-linked trialAbstract readClinical Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Israel journal of health policy research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02534142 (Colonoscopy Followup After Positive Fecal Occult Blood Test- Understanding Barriers to Adherence), which is not on this map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02534142 completednot on this map

Colonoscopy Followup After Positive Fecal Occult Blood Test- Understanding Barriers to Adherence

TypeobservationalSponsorMeuhedet. Healthcare OrganizationRan2015 to 2017Enrolled774ConditionsColorectal Cancer
3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Patient participation in gastrointestinal endoscopy - From patients' perspectives.Health expectations : an international journal of public participation in health care and health policy · 2020
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Revital AzulayDepartment of Management, MHA Program, Bar Ilan University, Ramat Gan, Israel. Azulay_revital@meuhedet.co.il.ORCID http://orcid.org/0000-0002-7523-0156
Liora ValinskyQuality Department, Meuhedet Health Care, 124 Eben Gvirol, Tel Aviv, Israel.
Fabienne HershkowitzQuality Department, Meuhedet Health Care, 124 Eben Gvirol, Tel Aviv, Israel.
Racheli MagneziDepartment of Management, MHA Program, Bar Ilan University, Ramat Gan, Israel.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundColorectal cancer (CRC) is a major cause of morbidity and mortality worldwide, but these can be reduced significantly with population screening using annual fecal occult blood tests (FOBT)A positive FOBT requires timely follow-up with colonoscopy to maximize screening benefits.. Several barriers to follow-up have been identified, with patient health behaviors and choices comprising a significant part of these. The Patient Activation Measure (PAM) assesses knowledge, skills, beliefs, and confidence in managing health. Increased patient activation is related to positive health outcomes. The aim of this study is to examine the association between patient empowerment, as reflected in the PAM, and follow-up colonoscopy within 90 days of a positive FOBT result.

methodsThis case-control study included 429 patients with a positive FOBT, 174 who had a colonoscopy within 90 days, and 255 who did not.. Participants completed a PAM telephone questionnaire (Cronbach's α = 0.785). We used both univariate and multivariate analyses to examine the effect of the PAM score as on the likelihood of undergoing colonoscopy, after adjusting for the independent variables.

resultsIn this study we did not find a significant association between PAM and adherence to colonoscopy, using both univariate and multivariate analyses (p = .334 and p = .697, whether PAM was defined as a continuous or as categorical, respectively).

conclusionsThis study was the first to examine the association between patient empowerment, as reflected in the patient activation measure, and adherence to colonoscopy after a positive FOBT. The findings did not support such an association. Further examination is required to clarify the relation between patient empowerment and activation and personal healthcare in general, and in the Israeli population in particular. Future policy should include specific, technical interventions to improve FOBT follow-up among all groups, until the patient-related barriers are better understood.

trial registrationClinicalTrials.gov Identifier: NCT02534142 https://clinicaltrials.gov/ct2/show/NCT02534142.

Indexed as

Occult BloodAgedAnalysis of VarianceCase-Control StudiesChi-Square DistributionColonoscopyColorectal NeoplasmsEarly Detection of CancerFemaleHumansIsraelMaleMass ScreeningMiddle AgedMultivariate AnalysisPatient ComplianceAdherenceColonoscopyFecal occult blood testPAMPatient activation measurementPositive colorectal cancer screening

Identifiers

PMID30577883
PMCPMC6303990

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.